The COVID‐19 Pandemic and Its Influence on Patients With Myotonic Dystrophy Type 1: Lessons Learned

The COVID‐19 Pandemic and Its Influence on Patients With Myotonic Dystrophy Type 1: Lessons Learned

ABSTRACT Introduction: Myotonic dystrophy type 1 (DM1) patients might represent a high‐risk population for severe COVID‐19 disease, as cardiopulmonary symptoms are part of the clinical spectrum of DM1. The COVID‐19 pandemic may have impacted DM1 patients. We aimed to determine the effect of the COVI...

Full description

Saved in:
Bibliographic Details
Main Authors: Vera E. A. Kleinveld, Johanna E. Bruijnes, Samuel Labrecque, Danielle E. G. Jeurissen‐Bekkering, Catharina G. Faber, Corinne G. C. Horlings
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:Brain and Behavior
Subjects:
COVID‐19
muscular dystrophies
myotonic dystrophy
pandemic
Online Access:https://doi.org/10.1002/brb3.70162
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/brb3.70162

Similar Items